全文获取类型
收费全文 | 2177篇 |
免费 | 112篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 102篇 |
妇产科学 | 20篇 |
基础医学 | 163篇 |
口腔科学 | 4篇 |
临床医学 | 226篇 |
内科学 | 469篇 |
皮肤病学 | 10篇 |
神经病学 | 114篇 |
特种医学 | 50篇 |
外国民族医学 | 1篇 |
外科学 | 327篇 |
综合类 | 335篇 |
预防医学 | 39篇 |
眼科学 | 60篇 |
药学 | 318篇 |
中国医学 | 33篇 |
肿瘤学 | 101篇 |
出版年
2023年 | 12篇 |
2022年 | 24篇 |
2021年 | 38篇 |
2020年 | 36篇 |
2019年 | 40篇 |
2018年 | 30篇 |
2017年 | 38篇 |
2016年 | 61篇 |
2015年 | 67篇 |
2014年 | 95篇 |
2013年 | 168篇 |
2012年 | 127篇 |
2011年 | 139篇 |
2010年 | 118篇 |
2009年 | 119篇 |
2008年 | 134篇 |
2007年 | 127篇 |
2006年 | 104篇 |
2005年 | 120篇 |
2004年 | 79篇 |
2003年 | 79篇 |
2002年 | 59篇 |
2001年 | 47篇 |
2000年 | 41篇 |
1999年 | 48篇 |
1998年 | 39篇 |
1997年 | 46篇 |
1996年 | 47篇 |
1995年 | 55篇 |
1994年 | 39篇 |
1993年 | 40篇 |
1992年 | 37篇 |
1991年 | 27篇 |
1990年 | 14篇 |
1989年 | 11篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有2376条查询结果,搜索用时 15 毫秒
71.
Tacke F Schöffski P Trautwein C Martin MU Stangel W Seifried E Manns MP Ganser A Petersen D 《British journal of haematology》1999,105(2):511-513
Serum concentrations of the thrombopoiesis-enhancing cytokines thrombopoietin (TPO), erythropoietin (EPO), interleukin (IL)-6 and IL-11 were determined in 119 healthy whole-blood (WBD) and 101 platelet donors (PD) prior to donation. The 90% TPO reference interval in WBD of 64-867 pg/ml (median 163, 100% range 45-7572) was significantly higher than in PD of 56-524 (median 122, range 44-801, P = 0.004), whereas their platelet counts were lower (P < 0.001). EPO levels were not different (WBD 7.7 +/- 3.8, PD 8.0 +/- 4.9 IU/l), IL-6 and IL-11 were below the detection limit in >/=90% of cases (IL-6 < 3.2 pg/ml, IL-11 < 31.2 pg/ml). None of the cytokines correlated with platelet counts, other blood parameters, or in the PD group with the frequency of platelet donations within the last 6 months. We conclude that plateletpheresis does not lead to a lasting increase of thrombopoietic cytokines and provide reference data for potential platelet mobilization strategies with recombinant growth factors. 相似文献
72.
Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria 总被引:5,自引:0,他引:5
J. A. L. Kurtzhals O. Rodrigues M. Addae J. O. O. Commey F. K. Nkrumah & L. Hviid 《British journal of haematology》1997,97(1):169-174
To study the importance of bone marrow inhibition in the pathogenesis of malarial anaemia, haematological and parasitological parameters were followed in patients with acute malaria. Three patient categories were studied, severe malarial anaemia (SA), cerebral malaria (CM) and uncomplicated malaria (UM). Red cell distribution width (RDW) was used as a surrogate marker of release of young erythrocytes and reticulocytes. Initially RDW was low in all patients in spite of markedly increased concentrations of erythropoietin (EPO). 3 d after institution of treatment and coinciding with parasite clearance RDW increased dramatically, reaching the highest levels 1–2 weeks later. Although severe anaemia was corrected by blood transfusion during the first 3 d of treatment, the peak RDW correlated significantly with the initial EPO levels. This suggests that Plasmodium falciparum infection causes a rapidly reversible suppression of the bone marrow response to EPO. Furthermore, the inhibition of bone marrow response was a general finding irrespective of initial haemoglobin levels suggesting that the severity of anaemia depends upon the degree of peripheral erythrocyte destruction in patients with suppressed bone marrow response to EPO. 相似文献
73.
74.
This study investigated whether bone marrow mesenchymal stem cell(BMSC) transplantation protected ischemic cerebral injury by stimulating endogenous erythropoietin. The model of ischemic stroke was established in rats through transient middle cerebral artery occlusion. Twenty-four hours later, 1 × 106 human BMSCs(h BMSCs) were injected into the tail vein. Fourteen days later, we found that h BMSCs promoted the release of endogenous erythropoietin in the ischemic region of rats. Simultaneously, 3 μg/d soluble erythropoietin receptor(s EPOR) was injected into the lateral ventricle, and on the next 13 consecutive days. s EPOR blocked the release of endogenous erythropoietin. The neurogenesis in the subventricular zone was less in the h BMSCs + s EPOR group than in the h BMSCs + heat-denatured s EPOR group. The adhesive-removal test result and the modified Neurological Severity Scores(m NSS) were lower in the h BMSCs + s EPOR group than in the heat-denatured s EPOR group. The adhesive-removal test result and m NSS were similar between the h BMSCs + heat-denatured s EPOR group and the h BMSCs + s EPOR group. These findings confirm that BMSCs contribute to neurogenesis and improve neurological function by promoting the release of endogenous erythropoietin following ischemic stroke. 相似文献
75.
目的观察促红细胞生成素(EPO)联合口服铁剂治疗对老年慢性心力衰竭(CHF)合并贫血患者血红蛋白、心功能、肾功能参数的影响。方法将87例心功能Ⅱ~Ⅳ级(NYHA)的老年CHF合并贫血(Hb〈110g/L)患者随机分至治疗组(n=44例)及对照组(n=43例)。在CHF常规治疗基础上,对照组给予口服铁剂,治疗组给予口服铁剂+皮下注射EPO。治疗4周后,观察两组血红蛋白、血肌酐、肌酐清除率、心功能、N末端前脑钠肽(NT-ProBNP)变化。结果(1)与治疗前相比,治疗后治疗组Hb明显升高[(112.1±3.4)g/LVS(98.3±5.4)g/L,P〈0.01],血清肌酐水平明显降低[(162.1±39.3)vmol/LVS(185.0±31.2) μmol/L,P〈0.053,肌酐清除率增加[(43.5±7.1)ml/minvs(38.2±9.O)ml/min,P〈0.053,NYHA心功能分级明显改善(2,5±0.5VS3.2±0.7,P〈0.01),血浆NT-ProBNP显著下降[(1636.3±436.7)ng/LVS(2217.8±960.2)ng/L,P〈0.053。对照组,上述参数均有所改善,但差异无显著性;(2)与对照组相比,治疗后治疗组Hb高于对照组,血清肌酐水平低于对照组,肌酐清除率高于对照组,NYHA心功能分级级别低于对照组,血浆NT-ProBNP低于对照组。结论在CHF合并贫血的老年患者中应用EPO和口服铁剂治疗,在纠正贫血基础上,可以进一步改善心功能(NYHA分级)、肾功能并降低血浆NT-ProBNP水平。 相似文献
76.
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation 下载免费PDF全文
Perry Maxwell Florinda Melendez‐Rodríguez Kyle B. Matchett Julian Aragones Nathalie Ben‐Califa Heidelinde Jaekel Ludger Hengst Herbert Lindner Andre Bernardini Ulf Brockmeier Joachim Fandrey Fritz Grunert Howard S. Oster Moshe Mittelman Mohamed El‐Tanani Markus Thiersch Edith M. Schneider Gasser Max Gassmann David Dangoor Robert J. Cuthbert Alexandra Irvine Anne Jordan Terence Lappin John Thompson Drorit Neumann 《British journal of haematology》2015,168(3):429-442
Recombinant human erythropoietin (rHuEPO) is an effective treatment for anaemia but concerns that it causes disease progression in cancer patients by activation of EPO receptors (EPOR) in tumour tissue have been controversial and have restricted its clinical use. Initial clinical studies were flawed because they used polyclonal antibodies, later shown to lack specificity for EPOR. Moreover, multiple isoforms of EPOR caused by differential splicing have been reported in cancer cell lines at the mRNA level but investigations of these variants and their potential impact on tumour progression, have been hampered by lack of suitable antibodies. The EpoCan consortium seeks to promote improved pathological testing of EPOR, leading to safer clinical use of rHuEPO, by producing well characterized EPOR antibodies. Using novel genetic and traditional peptide immunization protocols, we have produced mouse and rat monoclonal antibodies, and show that several of these specifically recognize EPOR by Western blot, immunoprecipitation, immunofluorescence, flow cytometry and immunohistochemistry in cell lines and clinical material. Widespread availability of these antibodies should enable the research community to gain a better understanding of the role of EPOR in cancer, and eventually to distinguish patients who can be treated safely by rHuEPO from those at increased risk from treatment. 相似文献
77.
78.
Henrik Dimke Matthew A. Sparks Benjamin R. Thomson Sebastian Frische Thomas M. Coffman Susan E. Quaggin 《Journal of the American Society of Nephrology : JASN》2015,26(5):1027-1038
Vascular endothelial growth factor A (VEGFA) production by podocytes is critical for glomerular endothelial health. VEGFA is also expressed in tubular epithelial cells in kidney; however, its physiologic role in the tubule has not been established. Using targeted transgenic mouse models, we found that Vegfa is expressed by specific epithelial cells along the nephron, whereas expression of its receptor (Kdr/Vegfr2) is largely restricted to adjacent peritubular capillaries. Embryonic deletion of tubular Vegfa did not affect systemic Vegfa levels, whereas renal Vegfa abundance was markedly decreased. Excision of Vegfa from renal tubules resulted in the formation of a smaller kidney, with a striking reduction in the density of peritubular capillaries. Consequently, elimination of tubular Vegfa caused pronounced polycythemia because of increased renal erythropoietin (Epo) production. Reducing hematocrit to normal levels in tubular Vegfa–deficient mice resulted in a markedly augmented renal Epo production, comparable with that observed in anemic wild-type mice. Here, we show that tubulovascular cross-talk by Vegfa is essential for maintenance of peritubular capillary networks in kidney. Disruption of this communication leads to increased renal Epo production and resulting polycythemia, presumably to counterbalance microvascular losses. 相似文献
79.
Zhen Qu Yong Jiang Ming Xu Ming Zhu Lu Bin Zhou Yitao Ding 《Archives of Medical Science》2015,11(5):978-981
Introduction
Uncontrolled angiogenesis plays an essential role in the occurrence, metastasis and malignant progression of hepatocellular carcinoma (HCC). This study aimed to investigate the expression of adrenomedullin (ADM) in human HCC and its correlation with the expression of erythropoietin receptor (EPOR), microvessel density (MVD) and the tumor pathological characteristics.Material and methods
Fresh tumor tissues were obtained from 30 HCC patients after hepatectomy. Ten cirrhotic and 10 normal liver tissues were included as controls. Expression of ADM and EPOR was determined by real-time PCR. The MVD was determined by counting the number of microvessels.Results
The MVD and the mRNA levels of ADM and EPOR in cancer tissues were significantly higher than those in the non-cancer tissues (p < 0.05). Expression of ADM was significantly correlated with the MVD and EPOR (r = 0.68 and 0.74, p < 0.01). Adrenomedullin and EPOR mRNA levels in HCC tissues were correlated with capsule invasion, pathological differentiation and tumor metastasis (p < 0.05).Conclusions
Our findings suggest that ADM and EPOR may serve as new regulatory factors involved in angiogenesis of HCC and represent novel targets for the treatment of HCC. 相似文献80.
Hongkai Zhang Ian A. Wilson Richard A. Lerner 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(39):15728-15733
A method is presented that uses combinatorial antibody libraries to endow cells with new binding energy landscapes for the purpose of regulating their phenotypes. Antibodies that are expressed in cells infected with a lentiviral combinatorial antibody library are selected directly for function rather than only for binding. The potential diversity space can be very large because more than one lentivirus can infect a single cell. Thus, the initial combinatorial diversity of ∼1.0 × 1011 members generated by the random association of antibody heavy and light chains is greatly increased by the reassortment of the antibody Fv domains themselves inside cells. The power of the system is illustrated by its ability to select unusual antibodies. Here, the selected antibodies are potent erythropoietin agonists whose ontogeny depends on recombination at the protein level of pairs of antibodies expressed in the same cell to generate heterodimeric bispecific antibodies. The obligate synergy between the different binding specificities of the antibody’s monomeric subunits appears to replicate the asymmetric binding mechanism of authentic erythropoietin. 相似文献